Mathias Hukkelhoven
Direktor/Vorstandsmitglied bei COMPUGEN LTD.
Vermögen: - $ am 30.04.2024
Profil
Mathias Hukkelhoven is an Independent Director at Compugen Ltd.
and an Independent Non-Executive Director at Centessa Pharmaceuticals Plc.
He previously worked as the Chairman-Portfolio Stewardship at Novartis Pharmaceuticals Corp.
and as the Senior VP-Global Head Drug Regulatory Affairs at Novartis Pharmaceuticals Corp.
from 2001 to 2009.
He also served as the SVP-Global Regulatory, Safety & Biometrics at Bristol-Myers Squibb (Israel) Ltd.
from 2010 to 2021.
Dr. Hukkelhoven obtained his undergraduate and doctorate degrees from Radboud University Nijmegen.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
19.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Mathias Hukkelhoven
Unternehmen | Position | Beginn |
---|---|---|
COMPUGEN LTD. | Direktor/Vorstandsmitglied | 01.03.2022 |
CENTESSA PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 01.07.2022 |
Ehemalige bekannte Positionen von Mathias Hukkelhoven
Unternehmen | Position | Ende |
---|---|---|
Bristol-Myers Squibb (Israel) Ltd. | General Counsel | 01.07.2021 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | General Counsel | 01.01.2009 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Ausbildung von Mathias Hukkelhoven
Radboud University Nijmegen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
COMPUGEN LTD. | Health Technology |
CENTESSA PHARMACEUTICALS PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
Bristol-Myers Squibb (Israel) Ltd. | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |